Safety and antiviral activity of albinterferon alfa-2b dosed every four weeks in genotype 2/3 chronic hepatitis C patients (Q42978321)
Jump to navigation
Jump to search
scientific article published on 7 May 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety and antiviral activity of albinterferon alfa-2b dosed every four weeks in genotype 2/3 chronic hepatitis C patients |
scientific article published on 7 May 2008 |
Statements
1 reference
Safety and antiviral activity of albinterferon alfa-2b dosed every four weeks in genotype 2/3 chronic hepatitis C patients (English)
1 reference
Vincent G Bain
1 reference
Kelly D Kaita
1 reference
Paul Marotta
1 reference
Eric M Yoshida
1 reference
Mark G Swain
1 reference
Robert J Bailey
1 reference
Keyur Patel
1 reference
Patrick W Cronin
1 reference
Erik Pulkstenis
1 reference
John G McHutchison
1 reference
G Mani Subramanian
1 reference
7 May 2008
1 reference
1 reference
Identifiers
1 reference